nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—BCHE—peripheral nervous system neoplasm	0.444	0.719	CbGaD
Mirabegron—ABCB1—peripheral nervous system neoplasm	0.174	0.282	CbGaD
Mirabegron—BCHE—Cisplatin—peripheral nervous system neoplasm	0.0515	0.201	CbGbCtD
Mirabegron—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0328	0.128	CbGbCtD
Mirabegron—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0328	0.128	CbGbCtD
Mirabegron—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0227	0.0888	CbGbCtD
Mirabegron—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0197	0.0768	CbGbCtD
Mirabegron—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0183	0.0714	CbGbCtD
Mirabegron—ABCB1—Vincristine—peripheral nervous system neoplasm	0.014	0.0547	CbGbCtD
Mirabegron—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0131	0.051	CbGbCtD
Mirabegron—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0128	0.0501	CbGbCtD
Mirabegron—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00875	0.0342	CbGbCtD
Mirabegron—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00839	0.0328	CbGbCtD
Mirabegron—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00825	0.0322	CbGbCtD
Mirabegron—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00769	0.03	CbGbCtD
Mirabegron—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00525	0.0205	CbGbCtD
Mirabegron—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00222	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000279	0.00221	CcSEcCtD
Mirabegron—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000279	0.00221	CcSEcCtD
Mirabegron—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000279	0.00221	CcSEcCtD
Mirabegron—Back pain—Vincristine—peripheral nervous system neoplasm	0.000278	0.0022	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00219	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00219	CcSEcCtD
Mirabegron—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.000277	0.00219	CcSEcCtD
Mirabegron—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.000277	0.00219	CcSEcCtD
Mirabegron—Constipation—Topotecan—peripheral nervous system neoplasm	0.000277	0.00219	CcSEcCtD
Mirabegron—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.000275	0.00218	CcSEcCtD
Mirabegron—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000274	0.00217	CcSEcCtD
Mirabegron—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000274	0.00217	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000273	0.00216	CcSEcCtD
Mirabegron—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000273	0.00216	CcSEcCtD
Mirabegron—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.000273	0.00216	CcSEcCtD
Mirabegron—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000271	0.00214	CcSEcCtD
Mirabegron—Neoplasm—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00213	CcSEcCtD
Mirabegron—Bladder pain—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00213	CcSEcCtD
Mirabegron—Cystitis noninfective—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.00213	CcSEcCtD
Mirabegron—Cystitis—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.00211	CcSEcCtD
Mirabegron—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000265	0.00209	CcSEcCtD
Mirabegron—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000264	0.00209	CcSEcCtD
Mirabegron—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000263	0.00208	CcSEcCtD
Mirabegron—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000262	0.00208	CcSEcCtD
Mirabegron—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000262	0.00208	CcSEcCtD
Mirabegron—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000262	0.00207	CcSEcCtD
Mirabegron—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000261	0.00206	CcSEcCtD
Mirabegron—Vaginal infection—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.00206	CcSEcCtD
Mirabegron—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000257	0.00204	CcSEcCtD
Mirabegron—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000257	0.00203	CcSEcCtD
Mirabegron—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000256	0.00202	CcSEcCtD
Mirabegron—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000255	0.00202	CcSEcCtD
Mirabegron—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000255	0.00202	CcSEcCtD
Mirabegron—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00202	CcSEcCtD
Mirabegron—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.00201	CcSEcCtD
Mirabegron—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000254	0.00201	CcSEcCtD
Mirabegron—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000254	0.00201	CcSEcCtD
Mirabegron—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000253	0.002	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000252	0.00199	CcSEcCtD
Mirabegron—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000252	0.00199	CcSEcCtD
Mirabegron—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00025	0.00198	CcSEcCtD
Mirabegron—Bladder pain—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00198	CcSEcCtD
Mirabegron—Neoplasm—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00198	CcSEcCtD
Mirabegron—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000248	0.00196	CcSEcCtD
Mirabegron—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000248	0.00196	CcSEcCtD
Mirabegron—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000248	0.00196	CcSEcCtD
Mirabegron—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00192	CcSEcCtD
Mirabegron—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.00191	CcSEcCtD
Mirabegron—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00189	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000239	0.00189	CcSEcCtD
Mirabegron—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.00188	CcSEcCtD
Mirabegron—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00187	CcSEcCtD
Mirabegron—Infection—Vincristine—peripheral nervous system neoplasm	0.000233	0.00184	CcSEcCtD
Mirabegron—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000232	0.00184	CcSEcCtD
Mirabegron—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00023	0.00182	CcSEcCtD
Mirabegron—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00023	0.00182	CcSEcCtD
Mirabegron—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000229	0.00181	CcSEcCtD
Mirabegron—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000227	0.0018	CcSEcCtD
Mirabegron—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000227	0.0018	CcSEcCtD
Mirabegron—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.0018	CcSEcCtD
Mirabegron—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000226	0.00179	CcSEcCtD
Mirabegron—Back pain—Etoposide—peripheral nervous system neoplasm	0.000225	0.00178	CcSEcCtD
Mirabegron—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000225	0.00178	CcSEcCtD
Mirabegron—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000224	0.00177	CcSEcCtD
Mirabegron—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00177	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000222	0.00175	CcSEcCtD
Mirabegron—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000221	0.00175	CcSEcCtD
Mirabegron—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00175	CcSEcCtD
Mirabegron—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00022	0.00174	CcSEcCtD
Mirabegron—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00022	0.00174	CcSEcCtD
Mirabegron—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000217	0.00172	CcSEcCtD
Mirabegron—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00171	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000215	0.0017	CcSEcCtD
Mirabegron—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.0017	CcSEcCtD
Mirabegron—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00169	CcSEcCtD
Mirabegron—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000214	0.00169	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000213	0.00169	CcSEcCtD
Mirabegron—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000212	0.00168	CcSEcCtD
Mirabegron—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000212	0.00168	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00166	CcSEcCtD
Mirabegron—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00166	CcSEcCtD
Mirabegron—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.00165	CcSEcCtD
Mirabegron—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.00165	CcSEcCtD
Mirabegron—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.00164	CcSEcCtD
Mirabegron—Infection—Cisplatin—peripheral nervous system neoplasm	0.000206	0.00163	CcSEcCtD
Mirabegron—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.00162	CcSEcCtD
Mirabegron—Rash—Topotecan—peripheral nervous system neoplasm	0.000204	0.00161	CcSEcCtD
Mirabegron—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000204	0.00161	CcSEcCtD
Mirabegron—Headache—Topotecan—peripheral nervous system neoplasm	0.000203	0.0016	CcSEcCtD
Mirabegron—Rash—Tretinoin—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000202	0.0016	CcSEcCtD
Mirabegron—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00159	CcSEcCtD
Mirabegron—Headache—Tretinoin—peripheral nervous system neoplasm	0.000201	0.00159	CcSEcCtD
Mirabegron—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000201	0.00159	CcSEcCtD
Mirabegron—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000201	0.00159	CcSEcCtD
Mirabegron—Constipation—Vincristine—peripheral nervous system neoplasm	0.0002	0.00159	CcSEcCtD
Mirabegron—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00159	CcSEcCtD
Mirabegron—Rash—Melphalan—peripheral nervous system neoplasm	0.0002	0.00158	CcSEcCtD
Mirabegron—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0002	0.00158	CcSEcCtD
Mirabegron—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000199	0.00157	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000197	0.00156	CcSEcCtD
Mirabegron—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00155	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00154	CcSEcCtD
Mirabegron—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00153	CcSEcCtD
Mirabegron—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000193	0.00153	CcSEcCtD
Mirabegron—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00152	CcSEcCtD
Mirabegron—Nausea—Topotecan—peripheral nervous system neoplasm	0.000192	0.00152	CcSEcCtD
Mirabegron—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000192	0.00152	CcSEcCtD
Mirabegron—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000192	0.00152	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00151	CcSEcCtD
Mirabegron—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000191	0.00151	CcSEcCtD
Mirabegron—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000191	0.00151	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000189	0.00149	CcSEcCtD
Mirabegron—Infection—Etoposide—peripheral nervous system neoplasm	0.000189	0.00149	CcSEcCtD
Mirabegron—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00149	CcSEcCtD
Mirabegron—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.00149	CcSEcCtD
Mirabegron—Nausea—Melphalan—peripheral nervous system neoplasm	0.000188	0.00149	CcSEcCtD
Mirabegron—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00148	CcSEcCtD
Mirabegron—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000185	0.00147	CcSEcCtD
Mirabegron—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000185	0.00147	CcSEcCtD
Mirabegron—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000184	0.00146	CcSEcCtD
Mirabegron—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00143	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00143	CcSEcCtD
Mirabegron—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000179	0.00142	CcSEcCtD
Mirabegron—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00142	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00142	CcSEcCtD
Mirabegron—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.0014	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.0014	CcSEcCtD
Mirabegron—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.00138	CcSEcCtD
Mirabegron—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00138	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00138	CcSEcCtD
Mirabegron—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00137	CcSEcCtD
Mirabegron—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00136	CcSEcCtD
Mirabegron—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000168	0.00133	CcSEcCtD
Mirabegron—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00132	CcSEcCtD
Mirabegron—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00132	CcSEcCtD
Mirabegron—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.00132	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00131	CcSEcCtD
Mirabegron—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.00131	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000164	0.0013	CcSEcCtD
Mirabegron—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000164	0.0013	CcSEcCtD
Mirabegron—Constipation—Etoposide—peripheral nervous system neoplasm	0.000162	0.00129	CcSEcCtD
Mirabegron—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00128	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00127	CcSEcCtD
Mirabegron—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.00127	CcSEcCtD
Mirabegron—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00016	0.00127	CcSEcCtD
Mirabegron—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00124	CcSEcCtD
Mirabegron—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000156	0.00123	CcSEcCtD
Mirabegron—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000155	0.00123	CcSEcCtD
Mirabegron—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000155	0.00123	CcSEcCtD
Mirabegron—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00122	CcSEcCtD
Mirabegron—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00122	CcSEcCtD
Mirabegron—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.00121	CcSEcCtD
Mirabegron—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.00121	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00121	CcSEcCtD
Mirabegron—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.00121	CcSEcCtD
Mirabegron—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000151	0.00119	CcSEcCtD
Mirabegron—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00119	CcSEcCtD
Mirabegron—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00015	0.00119	CcSEcCtD
Mirabegron—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00119	CcSEcCtD
Mirabegron—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000149	0.00118	CcSEcCtD
Mirabegron—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00117	CcSEcCtD
Mirabegron—Rash—Vincristine—peripheral nervous system neoplasm	0.000148	0.00117	CcSEcCtD
Mirabegron—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000148	0.00117	CcSEcCtD
Mirabegron—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.00117	CcSEcCtD
Mirabegron—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.00116	CcSEcCtD
Mirabegron—Headache—Vincristine—peripheral nervous system neoplasm	0.000147	0.00116	CcSEcCtD
Mirabegron—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00115	CcSEcCtD
Mirabegron—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.00114	CcSEcCtD
Mirabegron—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000142	0.00112	CcSEcCtD
Mirabegron—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000142	0.00112	CcSEcCtD
Mirabegron—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00111	CcSEcCtD
Mirabegron—Nausea—Vincristine—peripheral nervous system neoplasm	0.000139	0.0011	CcSEcCtD
Mirabegron—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.0011	CcSEcCtD
Mirabegron—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.0011	CcSEcCtD
Mirabegron—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00108	CcSEcCtD
Mirabegron—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000136	0.00108	CcSEcCtD
Mirabegron—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00108	CcSEcCtD
Mirabegron—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00108	CcSEcCtD
Mirabegron—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000134	0.00106	CcSEcCtD
Mirabegron—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00104	CcSEcCtD
Mirabegron—Rash—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00103	CcSEcCtD
Mirabegron—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000131	0.00103	CcSEcCtD
Mirabegron—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00013	0.00103	CcSEcCtD
Mirabegron—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00103	CcSEcCtD
Mirabegron—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00102	CcSEcCtD
Mirabegron—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000998	CcSEcCtD
Mirabegron—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000126	0.000994	CcSEcCtD
Mirabegron—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000974	CcSEcCtD
Mirabegron—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000973	CcSEcCtD
Mirabegron—Rash—Etoposide—peripheral nervous system neoplasm	0.00012	0.000948	CcSEcCtD
Mirabegron—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00012	0.000947	CcSEcCtD
Mirabegron—Headache—Etoposide—peripheral nervous system neoplasm	0.000119	0.000941	CcSEcCtD
Mirabegron—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000924	CcSEcCtD
Mirabegron—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000912	CcSEcCtD
Mirabegron—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.0009	CcSEcCtD
Mirabegron—Nausea—Etoposide—peripheral nervous system neoplasm	0.000113	0.000893	CcSEcCtD
Mirabegron—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000891	CcSEcCtD
Mirabegron—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000879	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000873	CcSEcCtD
Mirabegron—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000859	CcSEcCtD
Mirabegron—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000844	CcSEcCtD
Mirabegron—Infection—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000837	CcSEcCtD
Mirabegron—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000825	CcSEcCtD
Mirabegron—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000822	CcSEcCtD
Mirabegron—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000818	CcSEcCtD
Mirabegron—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000813	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000807	CcSEcCtD
Mirabegron—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000795	CcSEcCtD
Mirabegron—Infection—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000774	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.69e-05	0.000767	CcSEcCtD
Mirabegron—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000761	CcSEcCtD
Mirabegron—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000757	CcSEcCtD
Mirabegron—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.000742	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.19e-05	0.000727	CcSEcCtD
Mirabegron—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.000726	CcSEcCtD
Mirabegron—Constipation—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.00072	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.00071	CcSEcCtD
Mirabegron—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.7e-05	0.000689	CcSEcCtD
Mirabegron—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000686	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.000673	CcSEcCtD
Mirabegron—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000672	CcSEcCtD
Mirabegron—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000669	CcSEcCtD
Mirabegron—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000667	CcSEcCtD
Mirabegron—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000666	CcSEcCtD
Mirabegron—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.05e-05	0.000637	CcSEcCtD
Mirabegron—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000619	CcSEcCtD
Mirabegron—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.000616	CcSEcCtD
Mirabegron—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000604	CcSEcCtD
Mirabegron—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000596	CcSEcCtD
Mirabegron—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000576	CcSEcCtD
Mirabegron—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000559	CcSEcCtD
Mirabegron—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000557	CcSEcCtD
Mirabegron—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000551	CcSEcCtD
Mirabegron—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000533	CcSEcCtD
Mirabegron—Rash—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000531	CcSEcCtD
Mirabegron—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000531	CcSEcCtD
Mirabegron—Headache—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000528	CcSEcCtD
Mirabegron—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000515	CcSEcCtD
Mirabegron—Nausea—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.0005	CcSEcCtD
Mirabegron—Rash—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000491	CcSEcCtD
Mirabegron—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000491	CcSEcCtD
Mirabegron—Headache—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000488	CcSEcCtD
Mirabegron—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000463	CcSEcCtD
